SEC Comment Letter for Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114) (ARMP) — Mar 31, 2009

Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)
Date: March 31, 2009 · CIK: 0000921114 · Accession: 0000000000-09-016444

View on Edgar

AI Filing Summary & Sentiment

Date

March 31, 2009

Author

Not clearly detected

Form

UPLOAD

Company

Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)

Letter

Mail Stop 6010 March 31, 2009 David J. Poston Vice President and Chief Financial Officer Targeted Genetics Corporation 1100 Olive Way, Suite 100 Seattle, WA 98101

Re: Targeted Genetics Corporation Schedule 14A Filed March 23, 2009 File No. 0-23930

Dear Mr. Poston: We have completed our review of your preliminary proxy statement on Schedule 14A and have no further comments at this time. Sincerely, J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r

Show Raw Text

Mail Stop 6010                                                                                                   March 31, 2009
David J. Poston
Vice President and Chief Financial Officer
Targeted Genetics Corporation
1100 Olive Way, Suite 100  Seattle, WA 98101

Re: Targeted Genetics Corporation
Schedule 14A  Filed March 23, 2009
File No. 0-23930

Dear Mr. Poston:
  We have completed our review of  your preliminary proxy statement on
Schedule 14A and have no further comments at this time.
Sincerely,
           J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r

SecProbe.io